F. Umeda
Impact in
- Clinical Biochemistry top 0.5%
- Advanced Glycation End Products research
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Natural Antidiabetic Agents Studies
Papers in
-
- Metabolism, Diabetes, and Cancer 9
- Physiology 16
- Nitric Oxide and Endothelin Effects 9
- Co-authors
- H Nawata (40 shared papers)T. Hashimoto (12 shared papers)Toyoshi Inoguchi (14 shared papers)Hideo Utsumi (2 shared papers)Minako Imamura (2 shared papers)Tetsuji Etoh (1 shared paper)Hiroaki Sano (1 shared paper)Pan Li (1 shared paper)
- Journals
- Hormone and Metabolic Research (10 papers)Diabetes Research and Clinical Practice (5 papers)Diabetes (5 papers)Diabetologia (4 papers)Metabolism (3 papers)
- Partner nations
- JapanUnited StatesChina
In The Last Decade
F. Umeda
54 papers receiving 2.4k citations
F. Umeda's Hit Papers
Peers
Comparison fields: 5 of 107
- Clinical Biochemistry 386
- Endocrinology, Diabetes and Metabolism 536
- Physiology 686
- Biochemistry 175
- Biochemistry 111
Countries citing papers authored by F. Umeda
This map shows the geographic impact of F. Umeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Umeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Umeda more than expected).
Fields of papers citing papers by F. Umeda
This network shows the impact of papers produced by F. Umeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Umeda. The network helps show where F. Umeda may publish in the future.
Co-authors
The 25 scholars most cited alongside F. Umeda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C--dependent activation of NAD(P)H oxidase in cultured vascular cells. Hit paper breakdown → | 2000 | 1278 |
| 2 | 1998 | 165 | |
| 3 | 1995 | 131 | |
| 4 | 1998 | 86 | |
| 5 | 1994 | 76 | |
| 6 | 1994 | 75 | |
| 7 | 2001 | 63 | |
| 8 | 2000 | 52 | |
| 9 | 1984 | 48 | |
| 10 | 2001 | 46 | |
| 11 | 1994 | 35 | |
| 12 | 1991 | 34 | |
| 13 | 1989 | 30 | |
| 14 | 1988 | 24 | |
| 15 | 1989 | 21 | |
| 16 | 1990 | 21 | |
| 17 | 2002 | 16 | |
| 18 | 1993 | 15 | |
| 19 | Effect of plasma, serum and platelets from diabetics on DNA synthesis in cultured vascular smooth muscle cells. | 1985 | 14 |
| 20 | 1995 | 13 |
About F. Umeda
F. Umeda is a scholar working on Molecular Biology, Physiology, Surgery, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism, having authored 54 papers that have together received 2.4k indexed citations. Recurring topics across this work include Pancreatic function and diabetes (10 papers), Nitric Oxide and Endothelin Effects (9 papers), Metabolism, Diabetes, and Cancer (9 papers), Antiplatelet Therapy and Cardiovascular Diseases (7 papers), Advanced Glycation End Products research (5 papers), Cardiovascular Function and Risk Factors (5 papers), Atherosclerosis and Cardiovascular Diseases (5 papers) and Diabetes and associated disorders (3 papers). The work is most often cited by research in Clinical Biochemistry (386 citations), Endocrinology, Diabetes and Metabolism (536 citations), Physiology (686 citations), Biochemistry (175 citations) and Biochemistry (111 citations). F. Umeda has collaborated with scholars based in Japan, United States and China. Frequent co-authors include H Nawata, T. Hashimoto, Toyoshi Inoguchi, Hideo Utsumi, Minako Imamura, Tetsuji Etoh, Hiroaki Sano, Pan Li, Hong Yu and Masahiro Naruse. Their work appears in journals such as Hormone and Metabolic Research, Diabetes Research and Clinical Practice, Diabetes, Diabetologia and Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.